Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
HUHumacyte, Inc. logo

Humacyte, Inc. (HUMA)

NASDAQ Global Select · Currency in USD
$0.44 ▲ +0.02 (+5.40%)
At close: Oct 23, 4:00 PM ET. Market closed.
$0.44 ▲ +0.00 (+0.83%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$0.41
Open
$0.42
Day's Range
$0.40 – $0.44
52 Week Range
$0.34 – $1.78
Volume
2,593,766
Avg. Volume
8,943,414
Market Cap
$120.95M
Beta (5Y Monthly)
2.44
PE Ratio (TTM)
--
EPS (TTM)
-$0.41
Earnings Date
Nov 11, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$1.50

Profile: Humacyte, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
184
CEO
Laura E. Niklason

Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields. The company employs its distinct scientific and proprietary technology platform to produce human acellular vessels (HAVs).

Earnings

Next report: Wed, Nov 11, 2026
EPS estimate -$0.09 · Revenue est. $766.00K
DateEst.Actual
Aug 12, 2026-$0.11-$0.16Miss
May 13, 2026-$0.10-$0.09Beat
Mar 27, 2026-$0.13-$0.13Beat
Nov 12, 2025-$0.17-$0.14Beat
Aug 11, 2025-$0.15-$0.24Miss
May 13, 2025-$0.19$0.28Beat

Analyst view

Consensus price target
$1.50 ▲ +244.5%
Range $1.00 – $2.00
Rating: Buy
Buy 91% · Hold 9% · Sell 0%

Get free alerts on HUMA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.